| __timestamp | Teva Pharmaceutical Industries Limited | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1488000000 | 22223073 |
| Thursday, January 1, 2015 | 1525000000 | 6966842 |
| Friday, January 1, 2016 | 2111000000 | 9000499 |
| Sunday, January 1, 2017 | 1848000000 | 13741186 |
| Monday, January 1, 2018 | 1213000000 | 19040000 |
| Tuesday, January 1, 2019 | 1010000000 | 23559000 |
| Wednesday, January 1, 2020 | 997000000 | 31931000 |
| Friday, January 1, 2021 | 967000000 | 44981000 |
| Saturday, January 1, 2022 | 838000000 | 54234000 |
| Sunday, January 1, 2023 | 953000000 | 63806000 |
| Monday, January 1, 2024 | 998000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc. offer a fascinating contrast in their approach to research and development (R&D) spending over the past decade. From 2014 to 2023, Teva's R&D expenses have seen a significant decline of approximately 36%, from a peak in 2016. In contrast, Viking Therapeutics has steadily increased its R&D investment by nearly 187% over the same period. This divergence highlights Teva's strategic shift amidst industry challenges, while Viking's growing investment underscores its commitment to innovation. As the pharmaceutical landscape evolves, these spending patterns may influence their future market positions and product pipelines.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.